Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney Viability
Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney Viability
批准号:
10501992
负责人:
Yu Chen
金额:
$67.19万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2026-07-31
关键词:
3-DimensionalAcute Kidney FailureAlgorithmsAnatomyAreaBiologicalBiopsyCaliberCessation of lifeClinicClinicalClinical ResearchDataDevice or Instrument DevelopmentDevicesDiabetes MellitusDiscriminationDonor personEnd stage renal failureFailureGenerationsGoalsGoldGuidelinesHandHealthcareHistologicHistologyHistopathologyHumanHypertensionImageImaging DeviceImaging technologyImmunologicsIn SituIntelligenceKidneyKidney DiseasesKidney TransplantationLocationMapsMeasuresMedical HistoryMedical centerMethodsMorphologyNephrologyOklahomaOperating RoomsOperative Surgical ProceduresOptical Coherence TomographyOrgan DonorOrgan ProcurementsOrgan TransplantationOutcomePathologicPathologyPatientsProceduresProcessQuality of lifeRenal functionResolutionRiskRoboticsSamplingScanningSiteSpecificitySurfaceSystemTechnologyTestingTimeTissuesTrainingTranslatingTransplantationTubular formationUncertaintyValidationVisualWaiting ListsWeightalgorithm developmentbasecohortdeep learningdeep learning modeldelayed graft functiondiagnostic criteriafunctional statusgraft failuregraft functionhigh resolution imaginghigh riskhuman imagingimage processingimaging studyimplantationimprovedindexingkidney biopsykidney imagingnovelpost-transplantpredictive modelingprognosticprospectiverobot assistancescreeningtoolvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
There is a worldwide shortage of kidneys for transplantation due mainly to the fact that there is no reliable means
to determine the viability of kidneys available for transplant. There are unmet clinical needs to reduce the >8,000
deaths that occur each year from failures of finding viable kidney matches for transplant, to reduce the nearly 4-
year time on donor waitlists, and to reduce the number of failed transplants. The current process for screening
deceased donor kidneys uses two methods: 1) pathological scores based on anatomical features from a biopsy
(tubules, glomeruli, etc.) and 2) the Kidney Donor Profile Index (KDPI) derived from the donor’s medical history
(hypertension, diabetes, weight, etc.). However, clinical research indicates that those current methods have
limited discriminative power. Optical coherence tomography (OCT) is an imaging technology that can obtain
high-resolution, non-invasive, cross-sectional images of biological tissues in situ and in real time. We have
demonstrated that OCT can provide non-invasive, real-time, histopathological information of the kidney that is
impossible to obtain using any other known procedure. We have demonstrated that OCT imaging of human
kidney histopathology both prior to and following their transplant can be used to predict post-transplant renal
function. Furthermore, these preliminary trials have demonstrated that OCT imaging of human donor kidneys
with a hand-held unit in the operating room is safe and that the entire kidney can be evaluated within a relatively
short period of time. From a recently finished clinical study with 169 human transplant kidneys, we found that in
the expanded criteria donor (ECD) kidneys (or marginal kidneys), increased tubular lumen diameter was able to
predict delayed graft function (DGF) prior to implantation. In this proposal, we will develop a novel OCT device
with intelligent scanning and deep learning to evaluate donor kidney viability before transplant. By scanning the
whole kidney surface, our device intends to eliminate the uncertainty created by the biopsy/KDPI paradigm. The
OCT imaging studies will be correlated with post-transplant renal function in order to establish imaging algorithms
and guidelines for OCT imaging of kidneys prior to their transplant. Our central hypothesis is that more
comprehensive morphological parameters as measured by OCT can be used to determine post-transplantation
renal function. The specific aims of this proposal are: 1) Develop robot-assisted automatic 3D scanning OCT
imaging device to image human kidneys prior to their transplantation. 2) Develop deep-learning-based image
processing algorithms to quantitatively assess the OCT parameters as indicators of the functional status of
kidneys, using histology scoring system as the gold standard. 3) Derive the diagnostic criteria for assessing
transplant kidney function and perform prospective clinical studies to assess the accuracy of predicting post-
transplant function using OCT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
-
批准号:10522552
-
项目类别:
-
资助金额:$60.23万
-
财政年份:2022
-
负责人:Yu Chen
-
依托单位:
Iodine Catalyzed Cross-Coupling Reactions
-
批准号:10333396
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2022
-
负责人:Yu Chen
-
依托单位:
Iodine Catalyzed Cross-Coupling Reactions
-
批准号:10643819
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2022
-
负责人:Yu Chen
-
依托单位:
Evolution and inhibition of carbapenemase in beta-lactam resistance
-
批准号:10598501
-
项目类别:
-
资助金额:$73.04万
-
财政年份:2021
-
负责人:Yu Chen
-
依托单位:
Evolution and inhibition of carbapenemase in beta-lactam resistance
-
批准号:10385772
-
项目类别:
-
资助金额:$73.85万
-
财政年份:2021
-
负责人:Yu Chen
-
依托单位:
Patient-Derived Models of Prostate Cancer for Personalized Medicine
-
批准号:10472536
-
项目类别:
-
资助金额:$100.55万
-
财政年份:2019
-
负责人:Yu Chen
-
依托单位:
Patient-Derived Models of Prostate Cancer for Personalized Medicine
-
批准号:10219178
-
项目类别:
-
资助金额:$102.6万
-
财政年份:2019
-
负责人:Yu Chen
-
依托单位:
Patient-Derived Models of Prostate Cancer for Personalized Medicine
-
批准号:10683753
-
项目类别:
-
资助金额:$100.55万
-
财政年份:2019
-
负责人:Yu Chen
-
依托单位:
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
-
批准号:10224110
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2017
-
负责人:Yu Chen
-
依托单位:
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
-
批准号:9753189
-
项目类别:
-
资助金额:$48.17万
-
财政年份:2017
-
负责人:Yu Chen
-
依托单位:
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
-
批准号:10250362
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2017
-
负责人:Yu Chen
-
依托单位:
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
-
批准号:9446577
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2017
-
负责人:Yu Chen
-
依托单位:
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
-
批准号:10005211
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2017
-
负责人:Yu Chen
-
依托单位:
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
-
批准号:9384475
-
项目类别:
-
资助金额:$49.86万
-
财政年份:2017
-
负责人:Yu Chen
-
依托单位:
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
-
批准号:9080967
-
项目类别:
-
资助金额:$87.73万
-
财政年份:2016
-
负责人:Yu Chen
-
依托单位:
Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk
-
批准号:9899944
-
项目类别:
-
资助金额:$66.58万
-
财政年份:2016
-
负责人:Yu Chen
-
依托单位:
The NYU Women's Health Study
-
批准号:10165582
-
项目类别:
-
资助金额:$54.61万
-
财政年份:2015
-
负责人:Yu Chen
-
依托单位:
Three-Dimensional Image-Guided Development and Optimization of Molecular Regulating Bone Regenerative Scaffolds
-
批准号:8887845
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2015
-
负责人:Yu Chen
-
依托单位:
Three-Dimensional Image-Guided Development and Optimization of Molecular Regulating Bone Regenerative Scaffolds
-
批准号:9063060
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2015
-
负责人:Yu Chen
-
依托单位:
Structure-based Identification and Functional Characterization of SSH1 Inhibitors
-
批准号:8872959
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2015
-
负责人:Yu Chen
-
依托单位:
海外基金